Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular principles underlying hepatitis C virus diagnosis.

P Bean1, M Olive

  • 1Millennium Strategies, 418 N. Westfield Rd., Madison, WI 53717, USA. PamelaBean@home.com

American Clinical Laboratory
|August 17, 2001
PubMed
Summary

Hepatitis C virus (HCV) infection remains a significant public health concern in the U.S., with millions affected and unknown transmission routes in many cases. Molecular assays offer improved treatment efficacy for HCV patients, justifying their cost.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical determinants of decision-making for extended-window intravenous thrombolysis.

Neurologia·2026
Same author

Recommendations for the diagnosis, treatment, and follow-up of late-onset Pompe disease.

Neurologia·2025
Same author

Novel DES mutation presenting with isolated restrictive respiratory failure. Expanding the clinical spectrum.

Neurologia·2025
Same author

Implications of starting antiepileptic treatment prior to electroencephalography in first epileptic seizures.

Neurologia·2023
Same author

Implications of initiating antiseizure drugs prior to the performance of EEG in first epileptic seizures.

Neurologia·2021
Same author

Heterozygous CAPN3 missense variants causing autosomal-dominant calpainopathy in seven unrelated families.

Neuropathology and applied neurobiology·2020

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection rates are declining due to public health initiatives targeting intravenous drug users.
  • Despite these efforts, the overall prevalence of HCV in the U.S. remains high, with an estimated 3.9 million individuals infected.
  • For over 50% of HCV cases, the specific route of transmission is unknown, complicating control efforts.

Purpose of the Study:

  • To highlight the persistent public health challenge posed by Hepatitis C virus (HCV) in the United States.
  • To emphasize the significant morbidity and mortality associated with HCV infections.
  • To underscore the value of molecular assays in improving patient treatment outcomes.

Main Methods:

  • This study is a review of current epidemiological data on HCV infection in the U.S.

Related Experiment Videos

  • Analysis of existing public health policies and their impact on HCV transmission rates.
  • Evaluation of the role and benefits of molecular diagnostic assays in HCV management.

    • Main Results:

    • The rate of new HCV infections has decreased, but the overall number of infected individuals remains substantial.
    • A significant proportion of HCV infections have an unidentified source, indicating ongoing transmission challenges.
    • Molecular assays provide enhanced diagnostic capabilities for effective HCV patient management.

    Conclusions:

    • Hepatitis C virus (HCV) continues to be a major cause of disease and death in the U.S.
    • The widespread use of molecular assays is crucial for optimizing treatment strategies and improving patient outcomes.
    • Further research and public health interventions are needed to address the persistent burden of HCV infection.